Stories
Neurodegeneration
Understanding Genetic Medicines: Debunking Common Misconceptions with Andrew Adams
Understanding Cost-Effectiveness of Limited Duration Dosing of Therapy for Alzheimer’s disease
You Have Questions About Genetic Medicine -- Lilly Has Answers
A Scientist’s Story: Why Keep Working on Alzheimer’s Disease?
Lilly Comments on Proposed Medicare Coverage for Class of Alzheimer’s Treatments
PET Scan Imaging Is Crucial for Diagnosing Alzheimer’s Disease
PET Scan Imaging Is Crucial for Diagnosing Alzheimer’s Disease
How A Timely Alzheimer's Diagnosis Can Accelerate New Treatments
Lilly CEO Dave Ricks' Letter to Shareholders: 2020 Integrated Summary Report
Changing the Math on Alzheimer’s